US diagnostic test products dominant in Hong Kong
This article was originally published in Clinica
Executive Summary
Although US diagnostics and diagnostic instrument manufacturers expect a high - 10% - rate of growth of their products in the Chinese market over the coming two years, they are expecting a modest 2% growth in Hong Kong. However, the US is the dominant supplier to Hong Kong - which is entirely dependent upon imports for this sector, according to a recent report on the market from the US Commercial Service.